Zituvio Tablet
Product Images NDC 70710-1240

6 FDA label images from Zydus Pharmaceuticals (usa) Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zituvio (NDC 70710-1240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (1686e1de 8172 444b A267 Ad3bc7ca69f1 01)

Image (1686e1de 8172 444b A267 Ad3bc7ca69f1 01)
Chemical structure of sitagliptin, the active ingredient in ZITUVIO tablets, showing its molecular arrangement with characteristic nitrogen and fluorine atoms, including a trifluoromethyl group.*
FDA Label Image

Image (1686e1de 8172 444b A267 Ad3bc7ca69f1 02)

Image (1686e1de 8172 444b A267 Ad3bc7ca69f1 02)
A line graph showing the least squares mean change from baseline over 24 weeks for different diabetes treatments. The x-axis represents weeks (0 to 24) and the y-axis shows the LS mean change from baseline. Lines compare Placebo, Metformin 500 mg b.i.d., Metformin 1000 mg b.i.d., Sitagliptin 100 mg q.d., and two combination treatments of Sitagliptin 50 mg b.i.d. with Metformin 500 mg b.i.d. or 1000 mg b.i.d.*
FDA Label Image

Image (1686e1de 8172 444b A267 Ad3bc7ca69f1 03)

Image (1686e1de 8172 444b A267 Ad3bc7ca69f1 03)
A line graph showing LS mean change from baseline over 52 weeks with two sets of data points represented as circles and diamonds, both declining steeply from week 0 to week 12, then stabilizing with minor fluctuations through week 52. The x-axis is labeled 'Week' and the y-axis 'LS Mean Change from Baseline.'*
FDA Label Image

25 mg Label (1686e1de 8172 444b A267 Ad3bc7ca69f1 04)

25 mg Label (1686e1de 8172 444b A267 Ad3bc7ca69f1 04)
Packaging label for ZITUVIO (sitagliptin) tablets, 25 mg strength. The label shows the product name, active ingredient, and dosage form as film-coated tablets. It includes a 90-tablet count indication and mentions prescription use only (Rx only). The label also provides storage instructions, manufacturer details (Zydus Lifesciences Ltd., India), distributor information (Zydus Pharmaceuticals USA Inc., NJ), and a barcode.*
FDA Label Image

50 mg Label (1686e1de 8172 444b A267 Ad3bc7ca69f1 05)

50 mg Label (1686e1de 8172 444b A267 Ad3bc7ca69f1 05)
Label for ZITUVIO (sitagliptin) Tablets 50 mg oral tablets, manufactured by Zydus Lifesciences Ltd. and distributed by Zydus Pharmaceuticals (USA) Inc. The label states 90 tablets in the package, prescription only, with storage instructions and medication guide information. The label includes the NDC code 70710-1241-9 and emphasizes child resistance and moisture protection.*
FDA Label Image

100 mg Label (1686e1de 8172 444b A267 Ad3bc7ca69f1 06)

100 mg Label (1686e1de 8172 444b A267 Ad3bc7ca69f1 06)
Label for ZITUVIO (sitagliptin) Tablets 100 mg oral tablets by Zydus Pharmaceuticals (USA) Inc. The label includes dosage strength, child resistant packaging note, storage instructions (20-25°C, excursions 15-30°C), moisture protection advice, manufacturer and distributor details, and a reminder to dispense the enclosed Medication Guide. The package contains 90 tablets for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.